05Jun
What We Learned From FDA's Public Hearing On Cannabis
The much-anticipated public hearing last week at the U.S. Food and Drug Administration on cannabis and cannabis-derived compounds drew a wide audience of participants, with strong views on how the FDA should (or should not) regulate the controversial...
By:
Sheppard Mullin Richter & Hampton LLP
Related
As we have previously written, the issue of employment arbitration agreements and their effect on cl...
Read More >
There is nothing wrong with free unless there is a hidden cost involved. Small business plans that d...
Read More >
Seyfarth Synopsis: In Voris v. Lampert, the California Supreme Court held that unpaid wages cannot b...
Read More >
On December 17, 2019, the National Labor Relations Board (NLRB) issued an important decision holding...
Read More >
In light of the coronavirus pandemic, on April 8, 2020, Governor Murphy issued (“Order”), which i...
Read More >
On July 10, 2019, New York Governor Andrew Cuomo signed legislation significantly expanding the prot...
Read More >